ChatGPT Recommends Attending the Future Healthcare 100 Summit in May to Witness the Future of Medical Innovation

After the eras of UGC and PGC, people have ushered in the age of AIGC. At the beginning of 2023, ChatGPT “surrounded” everyone’s social media feeds, with users sharing various conversations they had with the model along with a wide range of exclamations. ChatGPT is a conversational large language model developed by OpenAI, an American artificial intelligence research laboratory. Thanks to its powerful text-processing capabilities and human-computer interaction features, it quickly became a highly sought-after new-generation AI product.

ChatGPT has become the internet’s most popular “ultimate assistant.” With its seemingly rare god’s-eye view, consulting ChatGPT for answers has turned into a fun game, offering people assistance and suggestions. Recently, as the organizing committee of the Top 100 prepared for the 7th Future Healthcare 100 Conference, it also engaged in a dialogue with ChatGPT to explore AIGC’s perspectives on innovation in the future healthcare industry.

01

Chatting with ChatGPT: A Brief Discussion on Future Healthcare Innovation

Over the past year, science and technology have continued to advance, machine learning models have been progressively refined, and tools and humans have co-evolved. In terms of technological progress, AIGC has further spurred creativity, driving greater transformation across various industries. The ecosystem of China’s medical and health industry is undergoing profound and far-reaching changes, opening up new horizons for imagination. Industry professionals are also breaking free from rigid mindsets, undaunted by challenges, to implement strategies for high-quality development, catch up with global frontier innovations, and seek answers to “future healthcare innovation.”

Certainly, the grand question of “Future Healthcare Innovation” itself has no fixed answer and cannot be resolved through simple conversations with ChatGPT. Judging from ChatGPT’s responses, it does provide thoughtful answers, though it inevitably strays off-topic at times. Nevertheless, it is an indisputable fact that industry professionals need to “maintain open minds and a global perspective, and timely access to the latest information and insights,” and that “global healthcare innovations can be tracked through academic journals, conferences, and other channels.” As a platform and vehicle for healthcare industry resources, byHosted by VCBeat VB100 and VCBeat Institute, in strategic partnership with Shanghai Zhangjiang Groupof the 7th Future Healthcare Top 100 Conference“Cutting-edge academic research insights, comprehensive industry perspective, and keen awareness of capital trends”integrated as one, scheduled forMay 5–7, 2023InShanghai Zhangjiang Science HallHosted to explore the innovative future of the broader health industry alongside peers, embarking on a new journey in medical innovation.

02

"The Future Path of Medical Innovation: 'No Questions Asked, East or West'"

Embarking on a New Journey in Healthcare Development with Striving Efforts.

On December 26, 2022, the National Health Commission issued an announcement stating that novel coronavirus infection would be reclassified from “Class B infectious disease managed as Class A” to “Class B infectious disease managed as Class B,” effective January 8, 2023. Amidst the new developments in epidemic prevention and control, the healthcare industry has entered a new phase of development. The year 2023 marks an epochal “beginning” for both niche and global markets, with everyone facing either smooth sailing or formidable challenges in this new era. On the entrepreneurial journey, founders inevitably encounter various risks and challenges, experiencing ups and downs. Pursuit and transcendence remain the enduring hallmark of China’s healthcare sector, requiring us to break through temporal and spatial constraints and press forward with courage.

As an innovator in future healthcare,“We” must have the courage to try and explore. No matter how turbulent the world becomes, we should remain true to ourselves, adhering to our principles and original aspirations. While we cannot dictate how the world treats “us,” we can determine our own attitude toward the world. Love what you love, follow your path, ask only for courage, seek only to flourish, and let go of all other concerns.

The Top 100 Future Healthcare Conference has accompanied innovators and entrepreneurs through six editions, and has now become the largest and most information-rich summit in China’s healthcare innovation industry for the integration of industry and capital. The 5th Top 100 Future Healthcare Conference (offline) attracted over 7,000 attendees, while the 6th edition (online) drew more than 35,000 participants. Over the past six years, the conference system has been continuously upgraded, gradually building an innovative ecosystem that links innovative enterprises, industrial capital, healthcare service institutions, research universities, and industrial parks. It serves as a benchmark guiding development, investment, and aggregation trends in China’s healthcare innovation sector for the current year and the foreseeable future.

With the comprehensive lifting of pandemic restrictions, offline exhibitions are making a high-profile comeback. In 2023, participating in offline exhibitions, engaging in face-to-face exchanges, and conducting on-site visits and experiences will become important options for companies to stay in sync with the market. The 7th Future Healthcare Top 100 Conference has been fully upgraded.3 Major Main ForumsFocusing on Trend Strategies and Innovation, Covering20+ Hot Fields, Pioneering New Breakthroughs in the Future of Healthcare,5 Major Categories of RankingsAuthoritative selections identify the core forces driving the industry, aggregating strategic announcements from listed companies, globally outstanding healthcare innovation projects, and scientific research achievements. We gauge capital market trends and provide insights into the future landscape of industry innovation.

03

Connecting the Future City of Medical Innovation, Charting the Blueprint for Its Development

Shanghai is the birthplace of China’s modern biopharmaceutical industry. In recent years, against the backdrop of a series of intensively rolled-out policies, Shanghai’s biopharmaceutical industry has gradually formed a “1+5+X” spatial layout, with the Zhangjiang Biopharmaceutical Innovation Core Area as its axis.

Since its initial foray into the biopharmaceutical industry in 1992, Zhangjiang Science City in Shanghai has, over the past 30 years, emerged as a premier domestic hub characterized by a high concentration of R&D institutions, robust innovation capabilities, and outstanding achievements in new drug development. Historically, Zhangjiang has consistently upheld principles of open innovation, independent innovation, and institutional innovation. Currently, Zhangjiang has gathered a diverse array of innovative biopharmaceutical enterprises: seven of the world’s top 10 pharmaceutical companies and 32 of the global top 100 have established their presence in Zhangjiang. The park is home to more than 600 biopharmaceutical startups and over 70 unicorns. Furthermore, the Yangtze River Delta Branch Centers of the Center for Drug Evaluation and Inspection and the Center for Medical Device Evaluation and Inspection under the National Medical Products Administration are both located in Zhangjiang, fostering a dynamic ecosystem where various entities mutually empower one another and drive iterative innovation. Looking ahead, Zhangjiang will remain committed to its original aspiration as the “China Pharma Valley” and strive to build a world-class biopharmaceutical industry cluster.

The 7th Future Healthcare Top 100 Conference, focusing on cutting-edge technologies and industrial innovation as well as development trends and venture capital dynamics, was ultimately held in Zhangjiang, Shanghai. In this cradle of medical innovation and city of the future, core industry resources converged in the pleasant spring month of May to jointly chart the blueprint for the development of medical innovation.

Conference Name:2023 7th Future Healthcare Top 100 Conference

Conference Time:May 5–7, 2023

Venue:Shanghai · Zhangjiang Science Hall

Organizer:VB100, VCBeat, VCBeat

Strategic Cooperation:Shanghai Zhangjiang Group